logo
Медицинский вестник
Северного Кавказа
Научно-практический журнал
Зарегистрирован в Федеральной службе
по надзору за соблюдением законодательства
в сфере массовых коммуникаций
и охране культурного наследия
ПИ №ФС77-26521 от 7 декабря 2006 года
ISSN 2073-8137
rus
русский
eng
english

Поиск по сайту




Адрес редакции
355017, Ставрополь, улица Мира, 310.

Телефоны
(8652) 35-25-11, 35-32-29.

E-mail
medvestnik@stgmu.ru

Рейтинг@Mail.ru

Биомаркеры и прогностический потенциал ротовой жидкости для ранней диагностики хронического пародонтита

[Обзоры]
Зуб Анна Андреевна; Гайворонская Татьяна Владимировна; Сирак Екатерина Сергеевна; Григорян Виктория Аликовна; Лайпанова Фериде Мекеровна; Щетинина Елизавета Евгеньевна; Ремизов Николай Олегович; Сирак Алла Григорьевна;

В настоящее время в большинстве стран диагностика хронического пародонтита включает определение ряда клинических параметров, некоторые из которых являются субъективными и могут отличаться по точности. Кроме того, клинические параметры не могут определить текущее состояние заболевания, так как должно произойти значительное повреждение тканей пародонта, прежде чем эти диагностические параметры смогут подтвердить развитие заболевания. В связи с этим поиск объективных критериев диагностики хронического пародонтита имеет важное значение для врача стоматолога. Диагностические тесты в стоматологическом кресле с использованием цельной слюны или десневой жидкости могут применяться клиницистами для очень ранней диагностики хронического пародонтита, оценки риска развития, прогрессирования и ответа на терапию путем выявления биомаркеров, достоверность результатов которых связана с чувствительностью и специфичностью. В обзоре рассматриваются пять перспективных биомаркеров, которые показали наиболее многообещающие результаты, приведены сравнительные показатели их чувствительности и специфичности и возможность изолированного применения для ранней диагностики пародонтита.

Скачать

Список литературы:
1. Helal O., Göstemeyer Krois J., Fawzy El Sayed K., Graetz C., Schwendicke F. Predictors for tooth loss in periodontitis patients: Systematic review and metaanalysis. J. Clin. Periodontol. 2019;46(7):699-712. https://doi.org/10.1111/jcpe.13118
2. Kassebaum N. J., Bernabé E., Dahiya M., Bhandari B., Murray C. J. L., Marcenes W. Global burden of severe periodontitis in 1990-2010: A systematic review and metaregression. J. Dent. Res. 2014;93(11):1045-1053. https://doi.org/10.1177/0022034514552491
3. Kwon T., Lamster I. B., Levin L. Current Concepts in the Management of Periodontitis. Int. Dent. J. 2021;71(6):462-476. https://doi.org/10.1111/idj.12630
4. Costa S. A., Ribeiro C. C. C., de Oliveira K. R., Alves C. M. C., Thomaz E. B. A. F. [et al.]. Low bone mineral density is associated with severe periodontitis at the end of the second decade of life: A population-based study. J. Clin. Periodontol. 2021;48(10):1322-1332. https://doi.org/10.1111/jcpe.13525
5. Tonetti M. S., Greenwell H., Kornman K. S. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J. Periodontol. 2018;89:S159-S172. https://doi.org/10.1002/JPER.18-0006
6. Ebersole J. L., Nagarajan R., Akers D., Miller C. S. Targeted salivary biomarkers for discrimination of periodontal health and disease(s). Front. Cell. Infect. Microbiol. 2015;5:1-12. https://doi.org/10.3389/fcimb.2015.00062
7. Al Rowis R., Al Moharib H. S., Al Mubarak A., Bhaskardoss J., Preethanath R. S., Anil S. Oral fluid-based biomarkers in periodontal disease – part 2. Gingival crevicular fluid. J. Int. Oral Health. 2014;6(5):126-135.
8. Ghallab N. A. Diagnostic potential and future directions of biomarkers in gingival crevicular fluid and saliva of periodontal diseases: Review of the current evidence. Arch. Oral Biol. 2018;87:115-124. https://doi.org/10.1016/j.archoralbio.2017.12.022
9. Cafiero C., Spagnuolo G., Marenzi G., Martuscelli R., Colamaio M., Leuci S. Predictive periodontitis: The most promising salivary biomarkers for early diagnosis of periodontitis. J. Clin. Med. 2021;10(7):1488. https://doi.org/10.3390/jcm10071488
10. Ray P., Manach Y. Le, Riou B., Houle T. T. Statistical evaluation of a biomarker. Anesthesiology. 2010;112(4):1023-1040. https://doi.org/10.1097/ALN.0b013e3181d47604
11. Melguizo-Rodríguez L., Costela-Ruiz V. J., ManzanoMoreno F. J., Ruiz C., Illescas-Montes R. Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies. Int. J. Mol. Sci. 2020;21(14):5173. https://doi.org/10.3390/ijms21145173
12. Srivastava N., Nayak P. A., Rana S. Point of careA novel approach to periodontal diagnosis-A review. J. Clin. Diagnostic Res. 2017;11(8):ZE01-ZE06. https://doi.org/10.7860/JCDR/2017/26626.10411
13. Al-Tarawneh S. K., Border M. B., Dibble C. F., Bencharit S. Defining salivary biomarkers using mass spectrometry-based proteomics: A systematic review. OMICS: A J. Integr. Biol. 2011;15(6):353-361. https://doi.org/10.1089/omi.2010.0134
14. Barros S. P., Williams R., Offenbacher S., Morelli T. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol. 2000. 2016;70(1):53-64. https://doi.org/10.1111/prd.12107
15. Bibi T., Khurshid Z., Rehman A., Imran E., Srivastava K. C., Shrivastava D. Gingival crevicular fluid (GCF): A diagnostic tool for the detection of periodontal health and diseases. Molecules. 2021;26(5):1-16. https://doi.org/10.3390/molecules26051208
16. Hamid H., Khurshid Z., Adanir N., Zafar M. S., Zohaib S. Covid-19 pandemic and role of human saliva as a testing biofluid in point-of-care technology. Eur. J. Dent. 2020;2: 1-7. https://doi.org/10.1055/S-0040-1713020
17. Arias-Bujanda N., Regueira-Iglesias A., Balsa-Castro C., Nibali L., Donos N., Tomás I. Accuracy of Single Molecular Biomarkers in Saliva for the Diagnosis of Periodontitis: A Systematic Review and Meta-Analysis. J. Clin. Periodontol. 2020;47(1):2-18. https://doi.org/10.1111/jcpe.13202
18. Arias-Bujanda N., Regueira-Iglesias A., Balsa-Castro C., Nibali L., Donos N., Tomás I. Accuracy of Single Molecular Biomarkers in Gingival Crevicular Fluid for the Diagnosis of Periodontitis: A Systematic Review and Meta-Analysis. J. Clin. Periodontol. 2019;46(12):1166-1182. https://doi.org/10.1111/jcpe.13188
19. Sukriti K. C., Wang X. Z., Gallagher J. E. Diagnostic sensitivity and specificity of host-derived salivary biomarkers in periodontal disease amongst adults: Systematic review. J. Clin. Periodontol. 2020;47(3):289-308. https://doi.org/10.1111/jcpe.13218
20. Izadi Borujeni S., Mayer M., Eickholz P. Activated matrix metalloproteinase-8 in saliva as diagnostic test for periodontal disease? A case – control study. Med. Microbiol. Immunol. 2015;204(6):665-672. https://doi.org/10.1007/s00430-015-0413-2
21. Sorsa T., Alassiri S., Grigoriadis A., Räisänen I. T., Pärnänen P. [et al.] Active MMP-8 (AMMP-8) as a grading and staging biomarker in the periodontitis classification. Diagnostics. 2020;10(2):1-10. https://doi.org/10.3390/diagnostics10020061
22. Sorsa T., Gursoy U. K., Nwhator S. O., Hernandez M., Tervahartiala T. [et al.] Analysis of matrix metalloproteinases in gingival crevicular fluid (GCF), mouthrinse and saliva for monitoring periodontal diseases. Periodontol. 2000. 2016;70:142-163. https://doi.org/10.1111/prd.12101
23. Sorsa T., Heikkinen A. M., Leppilahti J., Tervahartiala T., Nwhator S. [et al.] Active Matrix Metalloproteinase-8: Contributor to Periodontitis and a Missing Link Between Genetics, Dentistry, and Medicine. In: Bostanci N., Belibasakis G. (eds) Pathogenesis of Periodontal Diseases. Springer, Cham. – 2018. https://doi.org/10.1007/978-3-319-53737-5_5
24. Keles Yucel Z. P., Afacan B., Emingil G., Tervahartiala T., Kose T., Sorsa T. Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis. J. Periodontal. Res. 2020;55(6):887-894. https://doi.org/10.1111/jre.12781
25. Rangbulla V., Nirola A., Gupta M., Batra P., Gupta M. Salivary IgA, Interleukin-1beta and MMP-8 as salivary biomarkers in chronic periodontitis patients. Chin. J. Dent. Res. 2017;20(1):43-51. https://doi.org/10.3290/j.cjdr.a37741
26. Bazarnyi V. V., Polushina L. G., Maksimova A. Yu., Svetlakova E. N., Mandra Yu. V. Clinical and diagnostic characteristics of salivary matrix metalloproteinases as potential biomarkers in chronic periodontitis. Laboratornaya sluzhba. 2020;9(4):54-58. https://doi.org/10.17116/labs2020904154
27. Cheng R., Wu Z., Li M., Shao M., Hu T. Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review. Int. J. Oral Sci. 2020;12(1):1-9. https://doi.org/10.1038/s41368-019-0068-8
28. Schett G., Dayer J. M., Manger B. Interleukin-1 function and role in rheumatic disease. Nat. Rev. Rheumatol. 2016;12(1):14-24. https://doi.org/10.1038/nrrheum.2016.166
29. Murayama R., Kobayashi M., Takeshita A., Yasui T., Yamamoto M. MAPKs, activator protein-1 and nuclear factor-κB mediate production of interleukin-1β-stimulated cytokines, prostaglandinE 2 and MMP-1 in human periodontal ligament cells. J. Periodontal. Res. 2011;46(5):568-575. https://doi.org/10.1111/j.1600-0765.2011.01374.x
30. Polak D., Shapira L. An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J. Clin. Periodontol. 2018;45(2):150-166. https://doi.org/10.1111/jcpe.12803
31. Matsuura T., Ichinose S., Akiyama M., Kasahara Y., Tachikawa N., Nakahama KI. Involvement of CX3CL1 in the Migration of Osteoclast Precursors Across Osteoblast Layer Stimulated by Interleukin-1ß. J. Cell. Physiol. 2017;232(7):1739-1745. https://doi.org/10.1002/jcp.25577
32. Kinney J. S., Morelli T., Oh M., Braun T. M., Ramseier C. A. [et al.]. Crevicular fluid biomarkers and periodontal disease progression. J. Clin. Periodontol. 2014;41(2):113-120. https://doi.org/10.1111/jcpe.12194
33. Salminen A., Gursoy U. K., Paju S., Hyvärinen K., Mäntylä P. [et al.] Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J. Clin. Periodontol. 2014;41(5):442-450. https://doi.org/10.1111/jcpe.12234
34. Fujita Y., Ito H., Sekino S., Numabe Y. Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Odontology. 2012;100(2):215-221. https://doi.org/10.1007/s10266-011-0042-1
35. Ramseier C. A., Kinney J. S., Herr A. E., Braun T., Sugai J. V. [et al.] Identification of Pathogen and HostResponse Markers Correlated With Periodontal Disease. J. Periodontol. 2009;80(3):436-446. https://doi.org/10.1902/jop.2009.080480
36. Sánchez G. A., Miozza V. A., Delgado A., Busch L. Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment. J. Clin. Periodontol. 2013;40(12):1112-1117. https://doi.org/10.1111/jcpe.12164
37. Ebersole J. L., Schuster J. L., Stevens J., Dawson D., Kryscio R. J. [et al.] Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J. Clin. Immunol. 2013;33(1):271-279. https://doi.org/10.1007/s10875-012-9771-3
38. Wu Y. C., Ning L., Tu Y. K., Huang C. P., Huang N. T. [et al.] Salivary biomarker combination prediction model for the diagnosis of periodontitis in a Taiwanese population. J. Formos. Med. Assoc. 2018;117(9):841-848. https://doi.org/10.1016/j.jfma.2017.10.004
39. Kang S., Narazaki M., Metwally H., Kishimoto T. Historical overview of the interleukin-6 family cytokine. J. Exp. Med. 2020;217(5):e20190347. https://doi.org/10.1084/jem.20190347
40. Singh A. K., Haque M., Madarampalli B., Shi Y., Wildman B. J. [et al.] Ets-2 Propagates IL-6 TransSignaling Mediated Osteoclast-Like Changes in Human Rheumatoid Arthritis Synovial Fibroblast. Front. Imunol. 2021;12:746503. https://doi.org/10.3389/fimmu.2021.746503
41. Javed F., Al-Askar M., Al-Hezaimi K. Cytokine Profile in the Gingival Crevicular Fluid of Periodontitis Patients With and Without Type 2 Diabetes: A Literature Review. J. Periodontol. 2012;83(2):156-161. https://doi.org/10.1902/jop.2011.110207
42. Gümüş P., Nizam N., Lappin D. F., Buduneli N. Saliva and Serum Levels of B-Cell Activating Factors and Tumor Necrosis Factor-α in Patients With Periodontitis. J. Periodontol. 2014;85(2):270-280. https://doi.org/10.1902/jop.2013.130117
43. Javed F., Ahmed H. B., Saeed A., Mehmood A., Bain C. Whole Salivary Interleukin-6 and Matrix Metalloproteinase-8 Levels in Patients With Chronic Periodontitis With and Without Prediabetes. J. Periodontol. 2014;85(5):e130-e135. https://doi.org/10.1902/jop.2013.130514
44. Batool H., Nadeem A., Kashif M., Shahzad F., Tahir R., Afzal N. Salivary Levels of IL-6 and IL-17 Could Be an Indicator of Disease Severity in Patients with Calculus Associated Chronic Periodontitis. Biomed. Res. Int. 2018;2018:8531961. https://doi.org/10.1155/2018/8531961
45. Kardeşler L., Buduneli N., Çetinkalp Ş., Lappin D., Kinane D. F. Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes. Inflamm. Res. 2011;60(2):143-151. https://doi.org/10.1007/s00011-010-0248-7
46. De Lima Oliveira A. P., De Faveri M., Gursky L. C., Mestnik M. J., Feres M. [et al.] Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects. J. Clin. Periodontol. 2012;39(3):295-302. https://doi.org/10.1111/j.1600-051X.2011.01817.x
47. Stone M. J. Regulation of Chemokine-Receptor Interactions and Functions. Int. J. Mol. Sci. 2017;18(11):2415. https://doi.org/10.3390/ijms18112415
48. De Lima C. L., Acevedo A. C., Grisi D. C., Taba M., Guerra E. [et al.] Host-derived salivary biomarkers in diagnosing periodontal disease: Systematic review and meta-analysis. J. Clin. Periodontol. 2016;43(6):492-502. https://doi.org/10.1111/jcpe.12538
49. Carrillo-López N., Martínez-Arias L., Fernández-Villabrille S., Ruiz-Torres M. P., Dusso A. [et al.] Role of the RANK/RANKL/OPG and Wnt/beta-Catenin Systems in CKD Bone and Cardiovascular Disorders. Calcif. Tissue Int. 2021;108(4):439-451. https://doi.org/10.1007/s00223-020-00803-2
50. Nisha K. J., Suresh A., Anilkumar A., Padmanabhan S. MIP-1α and MCP-1 as salivary biomarkers in periodontal disease. Saudi Dent. J. 2018;30(4):292-298. https://doi.org/10.1016/j.sdentj.2018.07.002
51. Miranda T. S., Figueiredo N. de F., Figueiredo L. C., da Silva H. D. P., Rocha F. R. G., Duarte P. M. Cytokine profiles of healthy and diseased sites in individuals with periodontitis. Arch. Oral Biol. 2020;120:104957. https://doi.org/10.1016/j.archoralbio.2020.104957
52. Al-Sabbagh M., Alladah A., Lin Y., Kryscio R. J., Tho mas M. V. [et al.] Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. J. Periodontal. Res. 2012;47(3):389-395. https://doi.org/10.1111/j.1600-0765.2011.01445.x
53. Grande M. A, Belstrøm D., Damgaard C., Holmstrup P., Könönen E. [et al.] Salivary concentrations of macrophage activation-related chemokines are influenced by nonsurgical periodontal treatment: a 12-week follow-up study. J. Oral. Microbiol. 2020;12(1):1694383. https://doi.org/10.1080/20002297.2019.1694383
54. Fine D. H., Markowitz K., Furgang D., Fairlie K., Ferrandiz J. [et al.] Macrophage Inflammatory Protein-1α: A Salivary Biomarker of Bone Loss in a Longitudinal Cohort Study of Children at Risk for Aggressive Periodontal Disease? J. Periodontol. 2009;80(1):106-113. https://doi.org/10.1902/jop.2009.080296
55. Fine D. H., Markowitz K., Fairlie K., Tischio-Bereski D., Ferrandiz J. [et al.] Macrophage inflammatory protein-1α shows predictive value as a risk marker for subjects and sites vulnerable to bone loss in a longitudinal model of aggressive periodontitis. PLoS One. 2014;9(6):e98541. https://doi.org/10.1371/journal.pone.0098541
56. Hanioka T., Matsuse R., Shigemoto Y., Ojima M., Shizukuishi S. Relationship between periodontal disease status and combination of biochemical assays of gingival crevicular fluid. J. Periodont. Res. 2005;40(4):331-338. https://doi.org/10.1111/j.1600-0765.2005.00807.x
57. Ito H., Numabe Y., Hashimoto S., Uehara S., Wu Y. H., Ogawa T. Usefulness of hemoglobin examination in gingival crevicular fluid during supportive periodontal therapy to diagnose the pre-symptomatic state in periodontal disease. Clin. Oral Investig. 2021;25(2):487-495. https://doi.org/10.1007/s00784-020-03396-0
58. Mohanty P., Gujjari S. K., Nakum C. G. Salivary free hemoglobin and lactate dehydrogenase as biomarkers for periodontal disease in smokers. Quintessence Int. 2019;50(6):428-434. https://doi.org/10.3290/j.qi.a42478
59. Nomura Y., Okada A., Tamaki Y., Miura H. Salivary Levels of Hemoglobin for Screening Periodontal Disease: A Systematic Review. Int. J. Dent. 2018;2018:2541204. https://doi.org/10.1155/2018/2541204

Ключевые слова: хронический пародонтит, медиаторы воспаления, биомаркер


Учредители:
Ставропольская государственная медицинская академия
Государственный научно-исследовательский институт курортологии
Пятигорская государственная фармацевтическая академия